Tuesday, 19 November 2019

Strides Vivimed JV receives approval for Albendazole Tablets

12 December 2018 | News

This is the second generic approval by US FDA for Albendazole Tablets.

Image credit- washingtonpost.com

Image credit- washingtonpost.com

Strides  Pharma Science  Limited  (Strides)  has announced that its 50:50 JV Strides Vivimed Pte. Ltd, Singapore has received approval for Albendazole Tablets USP 200 mg from the United States Food & Drug Administration (US FDA).

This is the second generic approval by US FDA for Albendazole Tablets.

Albendazole Tablets is a generic version of Albenza Tablets of Amneal Pharmaceuticals, Inc.

According  to  IQVIA  MAT  data,  the  US  market  for  Albendazole  Tablets  USP  200  mg  is approximately US$ 100 Million.  

Albendazole  is  an  anthelmintic  medication  used  to  treat  certain  infections  caused  by tapeworm.  Albendazole  prevents  newly  hatched  insect  larvae  (worms)  from  growing  or multiplying in the body. 

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account